News
07-09-2020, 10:29 PM
Sheba Medical Center at Tel HaShomer and Immunicom, Inc. are initiating a ground-breaking clinical trial to evaluate the clinical effectiveness of the Immunicom LW-02 plasma filtration device as a monotherapy and in combination with an anti-PD-1 immune checkpoint inhibitor.
More... (https://www.news-medical.net/news/20200709/Immunicom-and-Sheba-Medical-Center-initiate-clinical-trial-to-evaluate-novel-cancer-treatment.aspx)
More... (https://www.news-medical.net/news/20200709/Immunicom-and-Sheba-Medical-Center-initiate-clinical-trial-to-evaluate-novel-cancer-treatment.aspx)